The results showed genomic regions susceptible to EBV-induced mutations and unveiled MUC19 to be a critical host factor in EBV latency, which was distinctively activated transcriptionally upon EBV infection. The gene discussed is MUC19; the disease is Epstein-Barr virus infection.